Show
Sort by
-
- Journal Article
- A1
- open access
Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain : a double-blind multicenter randomized placebo controlled three-arm study
-
Efficacy of bio-optimised curcuma extract (FLEXOFYTOL®) for painful knee osteoarthritis : data from copra, a multicenter randomised controlled study
-
Efficacy of bio-optimised curcuma extract (Flexofytol®) for painful knee osteoarthritis : data from COPRA, a multicenter randomised controlled study
-
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
-
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
-
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
-
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
-
Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients
-
Healthcare consumption and direct costs of rheumatoid arthritis in Belgium
-
- Journal Article
- A1
- open access
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment